Literature DB >> 207723

Thrombin generation and secretion of platelet Factor 4 during blood clotting.

M A Shuman, S P Levine.   

Abstract

We have studied the platelet release reaction and thrombin generation during the spontaneous clotting of whole blood in vitro. Both thrombin formation and secretion of platelet Factor 4 were detected at least 12 min before clotting (clotting time, 22--26 min). Initially, at low thrombin concentrations (2--5 ng/ml), there is a small increase in plasma platelet Factor 4 (less than 1% of the amount present in serum). This is followed by a gradual increase in both platelet Factor 4 and thrombin concentrations over a 12 to 20-min interval. Finally, 5 min 5 before clotting, there is a rapid increase in both thrombin generation and platelet secretion. Thus, we have shown that the release of platelet Factor 4 is a prolonged reactoin and the extent to which it occurs parallel thrombin generation. It is only when thrombin concentrations are high (45--90) ng/ml)--during the period of clot formation--that the major part of platelet Factor 4 secretion occurs. Release of platelet Factor 4, like fibrin formation, occurs in the last step of in vitro coagulation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207723      PMCID: PMC372628          DOI: 10.1172/JCI109010

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Content and thrombin-induced release of acid hydrolases in gel-filtered platelets from patients with storage pool disease.

Authors:  H Holmsen; C A Setkowsky; B Lages; H J Day; H J Weiss; M C Scrutton
Journal:  Blood       Date:  1975-07       Impact factor: 22.113

2.  Distribution of fibrinogen, and platelet factors 4 and XIII in subcellular fractions of human platelets.

Authors:  M J Broekman; R I Handin; P Cohen
Journal:  Br J Haematol       Date:  1975-09       Impact factor: 6.998

3.  Equilibrium binding of thrombin to platelets.

Authors:  B M Martin; W W Wasiewski; J W Fenton; T C Detwiler
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

4.  Subcellular localization of the heparin-neutralizing factor in blood platelets.

Authors:  M Da Prada; M Jakábová; E F Lüscher; A Pletscher; J G Richards
Journal:  J Physiol       Date:  1976-05       Impact factor: 5.182

5.  Development of a radioimmunoassay for human platelet factor 4.

Authors:  S P Levine; L S Krentz
Journal:  Thromb Res       Date:  1977-11       Impact factor: 3.944

6.  Recent advances in platelet lipid metabolism research.

Authors:  A J Marcus
Journal:  Ann N Y Acad Sci       Date:  1972-10-27       Impact factor: 5.691

7.  Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator.

Authors:  B Osterud; S I Rapaport; K K Lavine
Journal:  Blood       Date:  1977-05       Impact factor: 22.113

8.  Human thrombins. Production, evaluation, and properties of alpha-thrombin.

Authors:  J W Fenton; M J Fasco; A B Stackrow
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

9.  Interaction of coagulation factor Xa with human platelets.

Authors:  J P Miletich; C M Jackson; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

10.  The measurement of thrombin in clotting blood by radioimmunoassay.

Authors:  M A Shuman; P W Majerus
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

View more
  11 in total

1.  A general method for detecting protease activity via gelation and its application to artificial clotting.

Authors:  Steven C Bremmer; Jing Chen; Anne J McNeil; Matthew B Soellner
Journal:  Chem Commun (Camb)       Date:  2012-04-27       Impact factor: 6.222

2.  Calcium/Calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction.

Authors:  Zhen Wang; Roman Ginnan; Iskandar F Abdullaev; Mohamed Trebak; Peter A Vincent; Harold A Singer
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

Review 3.  Cellular consequences of thrombin-receptor activation.

Authors:  R J Grand; A S Turnell; P W Grabham
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

4.  Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.

Authors:  M A Shuman; S P Levine
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

5.  Hemostatic changes before and during electrophysiologic study and radiofrequency catheter ablation.

Authors:  Petr Parizek; L Haman; M Pleskot; M Pecka; J Bukac; P Stransky; J Maly
Journal:  Int J Hematol       Date:  2011-03-09       Impact factor: 2.490

6.  Relationship between platelet secretion and prothrombin cleavage in native whole blood.

Authors:  M E Rybak; H K Lau; B Tomkins; R D Rosenberg; R I Handin
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

7.  Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2).

Authors:  Bhanu Kanth Manne; Todd M Getz; Craig E Hughes; Osama Alshehri; Carol Dangelmaier; Ulhas P Naik; Steve P Watson; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

8.  alpha-Thrombin inhibits DNA synthesis in rat hepatocytes but not in hepatoma cells by receptor activation and proteolysis.

Authors:  Siddhartha Kar; Meifang Wang; Brian I Carr
Journal:  Mol Cell Biochem       Date:  2007-05-22       Impact factor: 3.396

9.  Activation of coagulation factor V by a platelet protease.

Authors:  W H Kane; J S Mruk; P W Majerus
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Postischemic dysfunction of the heart induced by small numbers of neutrophils via formation of hypochlorous acid.

Authors:  P Raschke; B F Becker; B Leipert; L M Schwartz; S Zahler; E Gerlach
Journal:  Basic Res Cardiol       Date:  1993 Jul-Aug       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.